Novo Integrated Sciences ( (NVOS) ) just unveiled an update.
On November 7, 2024, Robert Mattacchione announced his resignation as CEO of Novo Integrated Sciences, effective February 5, 2025, later extended to February 20, 2025, to ensure a smooth transition. Despite stepping down as CEO, he will remain the Company’s Chairman of the Board and Chairman of its subsidiary, Novo Healthnet Limited, with no disagreements affecting his decision.
More about Novo Integrated Sciences
Novo Integrated Sciences, Inc. operates in the healthcare industry, focusing on providing a range of healthcare services and products. The company is involved in offering innovative solutions and services through its subsidiaries, including Novo Healthnet Limited.
YTD Price Performance: 26.00%
Average Trading Volume: 142,560
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: $1.47M
For an in-depth examination of NVOS stock, go to TipRanks’ Stock Analysis page.